| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.092 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |